Loading...

BioSyent Inc.

BIOYF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$10.63
$-0.07(-0.65%)
U.S. Market opens in 7h 39m

BioSyent Inc. (BIOYF) Stock Overview

Explore BioSyent Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap122.2M
P/E Ratio18.10
EPS (TTM)$0.57
ROE0.23%
Fundamental Analysis

AI Price Forecasts

1 Month$11.17
3 Months$13.47
1 Year Target$10.63

BIOYF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioSyent Inc. (BIOYF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.46, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $10.63.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.10 and a market capitalization of 122.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.65%
5-Day Change
-2.39%
1-Month Change
-0.09%
3-Month Change
-1.02%
6-Month Change
37.34%
Year-to-Date (YTD) Change
11.66%
1-Year Change
34.56%
3-Year Change
85.51%
5-Year Change
75.12%
All-Time (Max) Change
1535.38%

Contact Information

https://www.biosyent.com
905-206-0013
2476 Argentia Road, Mississauga, ON, L5N 6M1

Company Facts

60 Employees
IPO DateFeb 22, 2012
CountryCA
Actively Trading

Frequently Asked Questions